| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP And COO | Exec VP And CFO
3 companies
Gordon Kevin K is an EVP And COO at IQV, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 24 sales. Those positions are worth an estimated $1.3M at current prices.
Our model assigns Gordon Kevin K a middling insider score of 51/100, based on 4 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +15.3%.
Gordon Kevin K's largest disclosed position is in IQV as EVP And COO, worth about $734K. The recent filings there lean toward selling, a net 220,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | PGNY Progyny, Inc. | Director | Sale+OE | 11,500 | $27.12 | $311,858.15 | -62.9% | - | - | |
| Sep 10, 2026 | PGNY Progyny, Inc. | Director | Sale+OE | 11,500 | $27.94 | $321,358.30 | -62.9% | - | - | |
| May 27, 2026 | PGNY Progyny, Inc. | Director | Sell | 5,500 | $24.99 | $137,445.00 | -37.1% | +1.3% | - | |
| Aug 11, 2025 | PGNY Progyny, Inc. | Director | Sell | 2,500 | $22.04 | $55,087.50 | -16.7% | +8.6% | +22.2% | |
| Dec 11, 2023 | PGNY Progyny, Inc. | Director | Sell | 2,500 | $35.93 | $89,825.00 | -20.2% | -0.0% | -56.2% | |
| May 24, 2023 | PGNY Progyny, Inc. | Director | Sell | 1,410 | $38.24 | $53,918.40 | -10.2% | -3.7% | -29.0% | |
| Jun 8, 2022 | VCYT Veracyte, Inc. | Director | Sale+OE | 15,000 | $18.50 | $277,501.50 | -63.2% | +0.5% | +39.2% | |
| Jan 4, 2021 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $48.98 | $489,798.36 | -100% | - | - | |
| Nov 12, 2020 | VCYT Veracyte, Inc. | Director | Sale+OE | 10,000 | $47.11 | $471,137.52 | -100% | - | - | |
| Jun 9, 2016 | IQV Iqvia Holdings Inc. | EVP And COO | Sell | 24,000 | $66.41 | $1,593,840.00 | -57.3% | - | - |